Skip to main content
PROTIA INC. logo

PROTIA INC. — Investor Relations & Filings

Ticker · 303360 ISIN · KR7303360002 KO Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2021-03-31 Regulatory Filings
Country KR South Korea
Listing KO 303360

About PROTIA INC.

https://www.protia.co.kr/en/main

PROTIA INC. is an in-vitro diagnostics (IVD) company that develops, manufactures, and sells a wide range of diagnostic kits and instruments. The company is particularly known for its flagship product, PROTIA Allergy-Q, a multiplex allergy diagnostic kit for the quantitative determination of allergen-specific IgE. Its portfolio also includes point-of-care testing (POCT) solutions like the ImmuneCheck IgG kit, diagnostic tests for infectious and autoimmune diseases, cancer, and antibiotic susceptibility, as well as the ANITIA line for companion animal allergy testing. In addition to its product offerings, PROTIA provides comprehensive protein analysis services, including LC-MS/MS and characterization analysis, aiming to contribute to early disease prediction and diagnosis through innovative technology.

Recent filings

Filing Released Lang Actions
조회공시요구(풍문또는보도)에대한답변(미확정)
Regulatory Filings Classification · 1% confidence The document is a formal response to a regulatory inquiry (조회공시 요구) regarding market rumors about a KOSDAQ listing. It is a standard regulatory disclosure document issued by the company to address market speculation, which falls under the category of general regulatory announcements.
2021-03-31 Korean
사업보고서 (2020.12)
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'ProteomeTech' (주식회사 프로테옴텍) for the fiscal year ending December 31, 2020. It includes the independent auditor's report from Samil PricewaterhouseCoopers, the financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. This is a comprehensive financial audit document, not an annual report (10-K) or a simple earnings release. FY 2020
2021-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a short regulatory announcement titled '감사보고서 제출' (Submission of Audit Report) dated 2021-03-23. It provides a summary of the audit opinion and key financial figures (assets, liabilities, revenue, etc.) as reported by the external auditor. Since the document is under 5,000 characters and serves as a formal notification that the audit report has been submitted/received, it falls under the 'Report Publication Announcement' category rather than the full audit report itself. FY 2020
2021-03-23 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details the shareholding status, changes in ownership, and the relationship between the reporter (Lim Kook-jin) and special related parties (special relationship shareholders) for the company ProteomeTech. This falls under the category of Major Shareholding Notification.
2021-03-18 Korean
기타주요경영사항(자율공시)(우선주의 보통주 전환청구)
Share Issue/Capital Change Classification · 1% confidence The document is a regulatory filing from ProteomeTech regarding the conversion of convertible preferred shares into common shares. This involves a change in the company's capital structure and share count. According to the provided definitions, 'Share Issue/Capital Change' (SHA) is the most appropriate category for announcements regarding new share issues or capital changes resulting from conversions.
2021-03-16 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for ProteomeTech. It contains the meeting agenda, details on board and auditor compensation, and management's reference materials (business overview, market analysis). This type of document is standard for providing shareholders with the necessary information to vote on resolutions at an upcoming Annual General Meeting. In the context of the provided categories, this is a Proxy Solicitation & Information Statement (PSI) as it provides the agenda and materials for shareholder voting.
2021-03-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.